Cargando…
A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer
The redox regulator NRF2 is hyperactivated in a large percentage of non-small cell lung cancer (NSCLC) cases, which is associated with chemotherapy and radiation resistance. To identify redox vulnerabilities for KEAP1/NRF2 mutant NSCLC, we conducted a CRISPR-Cas9-based negative selection screen for...
Autores principales: | Jiang, Chang, P. Ward, Nathan, Prieto-Farigua, Nicolas, Kang, Yun Pyo, Thalakola, Anish, Teng, Mingxiang, M. DeNicola, Gina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168196/ https://www.ncbi.nlm.nih.gov/pubmed/35667246 http://dx.doi.org/10.1016/j.redox.2022.102358 |
Ejemplares similares
-
Corrigendum to “A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer” [Redox Biol. 54 (2022) 102358]
por: Jiang, Chang, et al.
Publicado: (2022) -
Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
por: Torrente, Laura, et al.
Publicado: (2020) -
Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
por: DeBlasi, Janine M., et al.
Publicado: (2023) -
Recent advances in cancer metabolism: a technological perspective
por: Kang, Yun Pyo, et al.
Publicado: (2018) -
Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
por: Yoon, Sang Jun, et al.
Publicado: (2023)